Whitepaper “Brexit and Challenges faced by Medical Device Manufacturers” shares the high level phenomenal changes done by the UK in trading with other European states.

Steps to face the Brexit With-deal and No-deal scenario are the key substances discussed in each section of this whitepaper.

The main need for UK exiting Europe and timelines for Brexit were briefly discussed in this whitepaper. Key portions of this whitepaper cover the changes that need to be made by the medical device manufactures to their Quality policy, Regulations, Notified Body, labelling etc.,

Medicines and Healthcare products Regulatory Agency (MHRA) guidelines are discussed in a high-level to face the Brexit with or no deal event.

The entire process of triggering Article 50 and till dates improvements in Brexit are supplied in this paper, new guidelines and framework made to strengthen the UK at par in the global market.